Pembanding Perusahaan

Tentang

Ionis Pharmaceuticals is the leader in antisense technology, an approach that uses short strands of modified DNA to silence disease-causing genes at the RNA level. With Spinraza transforming SMA treatment and a rich pipeline of next-generation LICA platform drugs, Ionis is transitioning from a royalty-dependent model to a fully integrated rare disease company.

Pendapatan

$1.8B

Sinyal kesenjangan berita

Tidak ada data kesenjangan berita untuk ticker ini.

Sinyal institusional

Tidak ada sinyal 13F yang tercatat untuk ticker ini.

Pola kaskade

Tidak terdapat dalam pola kaskade yang dilacak.

Hubungan kunci

Tentang

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

Pendapatan

$130.5B

Sinyal kesenjangan berita

Sinyal institusional

Pola kaskade

Hubungan kunci